Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Osimertinib Plus Chemo Extends Survival in EGFR-Mutated NSCLC
October 2025
Osimertinib plus chemotherapy improved overall survival versus monotherapy in EGFR-mutated advanced NSCLC in a Phase III trial.
Read more
14 Aug 2025
Repurposed Parkinson’s Drug Benztropine Targets Tuberculosis
A Parkinson’s disease medication has demonstrated potent activity against Mycobacterium tuberculosis through a novel host-directed mechanism, offering a potential new avenue for combating the disease and addressing antimicrobial resistance.
12 Aug 2025
Oxygen Delivery Method Impacts Intubation Risk in ICU Patients
High-flow nasal cannula (HFNC) therapy may significantly reduce the need for intubation in critically ill patients with Pneumocystis jirovecii pneumonia (PjP), according to a new multicenter retrospective analysis.
12 Aug 2025
Interstitial Lung Disease Doubles Risk of Lung Cancer
Interstitial lung disease (ILD) is independently associated with a significantly higher risk of developing lung cancer, according to new findings from a large population-based cohort study that controlled for genetic factors.
9 Aug 2025
Long-Term Control Rare After Chronic Rhinosinusitis Surgery
Only one in four patients with chronic rhinosinusitis (CRS) maintain full clinical control more than 5 years after endoscopic endonasal surgery (EES), according to new long-term follow-up data using the updated European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) criteria.
7 Aug 2025
Lung Transplants Proceed in Men with High-Risk Prostate Cancer
Lung transplantation can be safely performed in men with newly diagnosed, localized high-risk prostate cancer prior to definitive cancer treatment, according to a new case review.
5 Aug 2025
E-Cigarette Flavor Bans Reduce Use in Adults, But Raise Cigarette Use in Youth
State-level restrictions on flavored e-cigarettes, implemented across several U.S. states, appear to have led to a decrease in e-cigarette use among young adults and older adults.
2 Aug 2025
Affordable, Fast Pneumonia Pathogen Detection for Low-Resource Settings
A novel, simplified loop-mediated isothermal amplification (LAMP) method for pneumonia pathogen detection has demonstrated significant potential for point-of-care applications in low-resource settings.
31 Jul 2025
Slow-Paced Breathing Reduces Anxiety and Boosts Brain Resilience
Slow-paced breathing (SB) significantly reduces state anxiety while enhancing brain activity, specifically in the midfrontal region, according to the results of a new study.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
23
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View